These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 11200379

  • 21. In vitro postantifungal effect, adhesion traits and haemolysin production of Candida dubliniensis isolates following exposure to 5-fluorocytosine.
    Ellepola AN, Chandy R, Khan ZU.
    Mycoses; 2015 Sep; 58(9):536-43. PubMed ID: 26201447
    [Abstract] [Full Text] [Related]

  • 22. Comparative studies on the postantifungal effect produced by the synergistic interaction of flucytosine and amphotericin B on Candida albicans.
    Scalarone GM, Mikami Y, Kurita N, Yazawa K, Miyaji M.
    Mycopathologia; 1992 Dec; 120(3):133-8. PubMed ID: 1494357
    [Abstract] [Full Text] [Related]

  • 23. Postantifungal effect and effects of low concentrations of amphotericin B and fluconazole on previously treated Candida albicans.
    Mínguez F, García MT, Lima JE, Llorente MT, Prieto J.
    Scand J Infect Dis; 1996 Dec; 28(5):503-6. PubMed ID: 8953682
    [Abstract] [Full Text] [Related]

  • 24. [In vitro susceptibility to antifungal agents of Candida strains isolated from patients with various diseases of the respiratory tract].
    Batura-Gabryel H, Wieczorek U, Mlynarczyk W.
    Pneumonol Alergol Pol; 1997 Dec; 65(5-6):355-9. PubMed ID: 9340063
    [Abstract] [Full Text] [Related]

  • 25. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents.
    Quindós G, Carrillo-Muñoz AJ, Arévalo MP, Salgado J, Alonso-Vargas R, Rodrigo JM, Ruesga MT, Valverde A, Pemán J, Cantón E, Martín-Mazuelos E, Pontón J.
    Chemotherapy; 2000 Dec; 46(6):395-401. PubMed ID: 11053905
    [Abstract] [Full Text] [Related]

  • 26. In vitro comparative evaluations of the postantifungal effect: synergistic interaction between flucytosine and fluconazole against Candida albicans.
    Scalarone GM, Mikami Y, Kurita N, Yazawa K, Uno J, Miyaji M.
    Mycoses; 1991 Dec; 34(9-10):405-10. PubMed ID: 1820519
    [Abstract] [Full Text] [Related]

  • 27. The postantibiotic effect of antifungal agents against common pathogenic yeasts.
    Turnidge JD, Gudmundsson S, Vogelman B, Craig WA.
    J Antimicrob Chemother; 1994 Jul; 34(1):83-92. PubMed ID: 7961219
    [Abstract] [Full Text] [Related]

  • 28. [Study on in vitro susceptibility of Candida spp. isolated from blood culture].
    Grandesso S, Sapino B, Mazzuccato S, Solinas M, Bedin M, D'Angelo M, Gion M.
    Infez Med; 2012 Mar; 20(1):25-30. PubMed ID: 22475657
    [Abstract] [Full Text] [Related]

  • 29. The effect of antifungal drugs in combination on the growth of Candida glabrata in solid and liquid media.
    Siau H, Kerridge D.
    J Antimicrob Chemother; 1998 Mar; 41(3):357-66. PubMed ID: 9578162
    [Abstract] [Full Text] [Related]

  • 30. In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species.
    Karlowsky JA, Hoban DJ, Zhanel GG, Goldstein BP.
    Int J Antimicrob Agents; 2006 Feb; 27(2):174-7. PubMed ID: 16414247
    [Abstract] [Full Text] [Related]

  • 31. [Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
    Czaika V, Tietz HJ, Schmalreck A, Sterry W, Schultze W.
    Mycoses; 2000 Feb; 43 Suppl 2():45-50. PubMed ID: 11291577
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.
    Di Bonaventura G, Spedicato I, Picciani C, D'Antonio D, Piccolomini R.
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4453-6. PubMed ID: 15504881
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA, Castanheira M, Messer SA, Jones RN.
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.